Allianz Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Allianz Asset Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-463,556	Closed	-$22.3M	–	2645
2020 Q1	$22.3M	Sell	463,556 -145,702	-24%	-$6.78M	0.03%	520
2019 Q4	$28.6M	Buy	609,258 +569,903	+1,448%	+$25.2M	0.03%	638
2019 Q3	$931K	Buy	+39,355	New	+$1.17M	﹤0.01%	2159

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Allianz Asset Management's RARX Position: Q2 2020 in Review

Allianz Asset Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 463,556 shares — an estimated $22.3M sold.

Allianz Asset Management first reported a position in RARX in Q3 2019 and held it in 3 quarters. The position peaked at $28.6M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Allianz Asset Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Allianz Asset Management sold 463,556 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $22.3M.
Allianz Asset Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
Allianz Asset Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $28.6M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.